PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Market Cap	1.86T -4.0%
Revenue (ttm)	2.12T -0.5%
Net Income	173.09B -10.7%
EPS	154.55 -10.7%
Shares Out	1.12B
PE Ratio	10.74
Forward PE	n/a
Dividend	108.00 (6.51%)
Ex-Dividend Date	Oct 29, 2025

Volume	23,400
Average Volume	40,055
Open	1,660.00
Previous Close	1,660.00
Day's Range	1,650.00 - 1,660.00
52-Week Range	1,325.00 - 1,750.00
Beta	-0.18
RSI	52.03
Earnings Date	Mar 17, 2026

About IDX:DVLA

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 1,311
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: DVLA

Financial Performance

In 2024, IDX:DVLA's revenue was 2.09 trillion, an increase of 10.40% compared to the previous year's 1.89 trillion. Earnings were 156.15 billion, an increase of 6.70%.